======= SAP130 ======= == Gene Information == * **Official Symbol**: SAP130 * **Official Name**: Sin3A associated protein 130 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79595|79595]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H0E3|Q9H0E3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SAP130&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SAP130|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609697|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a transcriptional repressor. May function in the assembly and/or enzymatic activity of the mSin3A corepressor complex or in mediating interactions between the complex and other regulatory complexes. {ECO:0000269|PubMed:12724404}. No Pfam Domain information is available for this gene. |Sin3-type complex| |nuclear speck| |negative regulation of transcription by RNA polymerase II| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|-2.74| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.48| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.42| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-2.34| |[[:results:exp83|Trametinib 10μM R02 exp83]]|-2.33| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-2.22| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.14| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-2.03| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2.03| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-2.01| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-1.96| |[[:results:exp345|Cidofovir 10μM R07 exp345]]|-1.95| |[[:results:exp34|Rotenone 20μM R00 exp34]]|-1.89| |[[:results:exp20|Etoposide 10μM R00 exp20]]|-1.88| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-1.85| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|-1.85| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-1.85| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-1.8| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-1.79| |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-1.77| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-1.75| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|-1.73| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.72| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|-1.71| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.71| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-1.71| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|1.78| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|1.88| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.92| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|2.01| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|2.37| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|2.43| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|2.8| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|2.85| ^Gene^Correlation^ |[[:human genes:i:ing1|ING1]]|0.727| |[[:human genes:b:brms1|BRMS1]]|0.628| |[[:human genes:s:sin3a|SIN3A]]|0.571| |[[:human genes:s:suds3|SUDS3]]|0.517| |[[:human genes:i:itpk1|ITPK1]]|0.468| |[[:human genes:a:arid4b|ARID4B]]|0.468| |[[:human genes:b:brd1|BRD1]]|0.45| |[[:human genes:u:ube2q1|UBE2Q1]]|0.448| |[[:human genes:r:rbm26|RBM26]]|0.443| |[[:human genes:p:pds5b|PDS5B]]|0.434| |[[:human genes:t:tspyl1|TSPYL1]]|0.43| |[[:human genes:s:spen|SPEN]]|0.422| |[[:human genes:z:zfc3h1|ZFC3H1]]|0.409| |[[:human genes:f:fam204a|FAM204A]]|0.405| |[[:human genes:f:fam60a|FAM60A]]|0.402| Global Fraction of Cell Lines Where Essential: 8/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|1/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|1/14| |ovary|1/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|1/1| |skin|0/24| |soft tissue|1/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5959 * **Expression level (log2 read counts)**: 5.37 {{:chemogenomics:nalm6 dist.png?nolink |}}